Clinical Trials

70 enrolled

Breast Neoplasms

NCT07206056 2026-06-03

TulmiSTAR-01

Phase 1/2 Recruiting

188 enrolled

Progressive Metastatic Castrate Resistant Prostate Cancer

NCT07023289 2026-06-02

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

140 enrolled

Neoplasms, Colorectal Neoplasms

NCT07563595 2026-05-04

ELENI

Not yet recruiting

500 enrolled

Breast Neoplasms

NCT04844866 2026-04-29

DALY 2-EU

LymphoidOther hematologic neoplasm

213 enrolled

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Hematologic Neoplasms

NCT06585410 2026-04-22

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

Phase 3 Recruiting

369 enrolled

Dermatologic

Skin Neoplasms

NCT07155187 2026-03-11

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Phase 2/3 Recruiting

430 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT05316701 2026-03-04

Orca-T

Phase 3 Active not recruiting

187 enrolled 15 charts

LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06855277 2026-02-24

AcTFirst

Phase 3 Recruiting

940 enrolled

Prostatic Neoplasms

NCT04876651 2026-02-20

The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only

Phase 3 Terminated

16 enrolled

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT04485949 2026-02-10

A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma

93 enrolled

CNS

Glioblastoma

NCT05405595 2026-01-07

ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

Phase 1/2 Recruiting

186 enrolled

Other solid neoplasm

Advanced/Metastatic Solid Tumors

NCT03602859 2025-12-31

FIRST

Phase 3 Active not recruiting

1,400 enrolled 18 charts

Gynecologic

Ovarian Neoplasms

NCT03523338 2025-12-10

An Expanded Access Protocol for Apalutamide Treatment of Participants With Non-Metastatic Castration-Resistant Prostate Cancer

No longer available

Phase 3 Not yet recruiting

Prostatic Neoplasms

NCT07181239 2025-09-18

Study of CM336 in Relapsed or Refractory Multiple Myeloma Patients

280 enrolled

478 enrolled 16 charts 1 FDA

Multiple Myeloma

NCT03778931 2025-09-15

EMERALD

Phase 3 Completed

Phase 2 Active not recruiting

Breast Neoplasms

NCT07150663 2025-09-08

Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer

Phase 3 Recruiting

134 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05608044 2025-09-04

A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer

234 enrolled

Diabetes Mellitus, Insulin-Dependent, 12, Parkinson Disease 4, Autosomal Dominant Lewy Body, Colorectal Neoplasms

NCT04467593 2025-08-05

MATTERS

16 enrolled

Advanced Cancer

NCT01711671 2025-08-03

A Study of DKN-01 and Lenalidomide/Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Phase 1 Completed

8 enrolled

184 enrolled 30 charts 1 FDA

Multiple Myeloma

NCT03575351 2025-08-03

TRANSFORM

Phase 3 Completed

Lymphoid

Lymphoma, Non-Hodgkin, Recurrence

NCT03194646 2025-07-28

ASTEROID 6

Phase 3 Terminated

1,272 enrolled 16 charts

Leiomyoma

NCT06504524 2025-06-27

A Study to Compare the Effects of Elranatamab (PF 06863135) Versus Standard of Care (SOC) in Patients With Multiple Myeloma (MM) in Germany and US

633 enrolled 15 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT06309615 2025-05-29

PDxBRUTILITY

Not yet recruiting

300 enrolled

Breast Neoplasms

NCT05801965 2025-05-25

A Digital Therapeutic Solution for Cancer Patients

GastrointestinalGenitourinaryThoracic

48 enrolled

Lung Neoplasms, Motor Activity, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Medication Adherence

NCT06989450 2025-05-25

Digital Patient Support Program for Self-efficacy and Medication Adherence in Women on Adjuvant Endocrine Treatment for Breast Cancer

Phase NA Recruiting

140 enrolled

Breast Neoplasms, Neoplasms, Medication Adherence

NCT06592222 2025-05-20

A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma as Compared With Standard of Care Therapies

4 enrolled

Phase 3 Not yet recruiting

Multiple Myeloma

NCT06961188 2025-05-07

Clinical Study on Nanocrystalline Megestrol Acetate for Appetite Improvement and Weight Gain in Pre-Cachexia and Cachexia Stages Key Terminology Analysis

174 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT05236257 2024-12-10

EPI VITRAKVI

93 enrolled 14 charts

Sarcoma

Locally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene Fusion

NCT05932290 2024-10-29

A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma

514 enrolled 16 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT06636682 2024-10-21

FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer

100 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT04982627 2024-07-03

BNICHAT

4 enrolled

Lymphoid

Criminal Behavior, Lymphoma, Follicular, Opioid-Related Disorders

NCT05565391 2024-05-21

A Study to Learn About the Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma

508 enrolled 16 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT04099888 2023-09-11

RELEASE

Phase 2 Terminated

41 enrolled 17 charts

Bile Duct Neoplasms, Cholangiocarcinoma

NCT05266430 2023-08-09

IL

Terminated

2 enrolled

Dermatologic

Uveal Melanoma

NCT00556374 2023-07-27

Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy

Phase 3 Completed

3,420 enrolled 19 charts

Breast Neoplasms

NCT03501173 2023-07-25

GURC

374 enrolled

Prostatic Neoplasms

NCT01468623 2023-07-19

PROFUSE

Phase 4 Terminated

51 enrolled

233 enrolled 26 charts 1 FDA

Neoplasm Metastasis, Colorectal Neoplasms

NCT04733833 2023-02-01

A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19

Phase 2 Completed

5 enrolled

Lymphoid

COVID-19, Lymphoma, Follicular

NCT04963972 2022-05-10

Digital and Behavioral Tele-Health Tapering Program for Lowering Dependence on Opioids in Patients Undergoing Surgery

Phase NA Unknown

272 enrolled

Head & Neck

Head and Neck Neoplasms

NCT02107937 2022-05-04

Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian Carcinoma

Phase 2 Completed

136 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT03329690 2022-03-18

DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01]

Phase 2 Completed

Adenocarcinoma, Gastrointestinal Neoplasms

NCT02549222 2022-02-18

PIPER

2,291 enrolled

Transfusion-Related Acute Lung Injury, Neoplasms

NCT04446429 2021-12-10

Anti-Androgen Treatment for COVID-19

268 enrolled 8 charts

COVID-19, Alopecia, Prostatic Hyperplasia, Prostatic Neoplasms, Severe Acute Respiratory Syndrome

NCT04572776 2021-11-09

Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain

Phase 3 Withdrawn

Cancer Pain, Pain, Pain, Intractable

NCT03393000 2021-07-22

INTACT

Phase 3 Terminated

19 enrolled 8 charts

CNS

Glioblastoma

NCT02448810 2021-05-25

Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer

Phase 2 Terminated

115 enrolled 22 charts